SEC61A1 and neoplasm: Based on this hypothesis, we established our new therapy approach to inhibit tumor cell migration by a combinatory inhibition of two important processes that essentially control cellular Ca2+ homeostasis at the level of the ER membrane: first, we block CaM by TFP, which leads to an elevated Ca2+ leakage from the ER because of an inefficient closure of the SEC61 channel.